108. Hoseth E., Joergensen A., Ebbesen F., Moeller M. Blood glucose levels in a population of healthy, breast fed, term infants of appropriate size for gestational age // Arch. Dis. Child Fetal Neonatal Ed. 2000. Vol. 83, N 2. P. 117–119.
109. Hoveyda N., Shield J. P., Garrett C., Chong W. K., Beardsall K, Bentsi-Enchill E., Mal-lya H., Thompson М. H. Neonatal diabetes mellitus and cerebellar hypoplasia/agenesis: report of a new recessive syndrome // J. Med. Genet. 1999. Vol. 36, N 9. P. 700–704.
110. Hume R., Burchell A. Abnormal expression of glucose-6-phosphatase in preterm infants // Archives of disease in childhood. 1993. Vol. 68. P. 202–204.
111. Hussain K, Aynsley-Green A., Stanley C. A. Medications used in the treatment of hypoglycemia due to congenital hyperinsulinism of infancy (HI) // Pediatr Endocrinol Rev. 2004; Vol. 2 Suppl 1. P. 163–167.
112. Iafusco D., StaziM. A., Cotichini R., Cotellessa М., Martinucci М. E., Mazzella М., Cherubini V, Barbetti F., Martinetti М., Cerutti F., Prisco F. Early Onset Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology // Diabetologia. 2002. Vol45(6). P. 798–804.
113. Iglesias Platas Thio Lluch М., Pociello Alminana N., Morillo Palomo A., Iriondo SanzM., Krauel Vidal X. Continuous glucose monitoring in infants of very low birth weight. Neonatology. 2009. Vol. 95. P. 217–223.
114. Inder T. How low can I go? The impact of hypoglycemia on the immature brain. Pediatrics. 2008;Vol. 122, N 2. P. 440–441.
115. JonssonJ., Carlsson L., Edlund Т., EdlundH. Insulin-promoter-factor 1 is required for pancreas development in mice // Nature, 1994 Oct 13. Vol. 371, N 6498. P. 606–609.
116. Julier C., Nicolino M. Wolcott-Rallison syndrome // Orphanet. J. Rare Dis. 2010. Vol. 4. P. 5–29.
117. Kalhan S. C., Oliven A., King К. C., Lucero C. Role of glucose in the regulation of endogenous glucose production in the human newborn // Pediatric research. 1986. Vol. 20. P. 49–52.
118. Kalhan S. C., Parimi P. S. Metabolic and endocrine disorders, part one: disorders of carbohydrate metabolism // Neonatal-Perinatal Medicine: Diseases of the Fetus and Newborn.
8. / Martin R. J., Fanaroff A. A., Walsh М. C., editors. Philadelphia: Mosby-Elsevier, 2006. P. 1467–1491.
119. Kalhan S. C., Parimi P., Van Beek R., Gilfillan C., Saker F., Gruca L., Sauer P. J. Estimation of gluconeogenesis in newborn infants // Am. J. Physiol. Endocrinol. Metab. 2001. Vol. 281, N 5. P. 991–997.
120. Kalhan S. C., Savin S. М., Adam P. A. J. Measurement of glucose turnover in the human newborn with glucose-l-13C // Journal of clinical endocrinology and metabolism. 1976. Vol. 43. P. 704–707.
121. KatzL. E., Ferry R. J., Stanley C. A., Collett-SolbergP. F., Baker L., Cohen P. Suppression of insulin oversecretion by subcutaneous recombinant human insulin-like growth factor I in children with congenital hyperinsulinism due to defective beta-cell sulfonylurea receptor//J. Clin. Endocrinol. Metab. 1999. Vol. 84. P. 3117–3124.
122. Kayiran S. М., Giirakan B. Screening of blood glucose levels in healthy neonates // Singapore Med. J. 2010. Vol. 51, N 11. P. 853–835.
123. Kinnala A., Rikalainen H., Lapinleimu H., Parkkola R., Kormano М., Kero P. Cerebral magnetic resonance imaging and ultrasonography findings after neonatal hypoglycemia // Pediatrics. 1999. Vol. 103. P. 724–729.
124. Koivisto М., Blanco-Sequeiros М., Krause U. Neonatal sympomatic and asymptomatic hypoglycaemia: a follow-up study // Developmental medicine and child neurology. 1972. Vol. 14. P. 603–614.
125. Kompare М., Rizzo W. B. Mitochondrial fatty-acid oxidation disorders // Semin. Pediatr. Neurol. 2008. Vol. 15. P. 140–149.
126. Krinsley J. S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients // Mayo Clin. Proc. 2004. Vol. 79. P. 992–1000.
127. Ktorza A., Bihoreau М. Т., Nurjhan N., Picon L., Girard J. Insulin and glucagon during the perinatal period: secretion and metabolic effects on the liver // Biology of the neonate. 1985. Vol. 48. P. 204–220.
128. Kumari S., Bhargava S. K., Ahmed S. H., Ghosh S. Transient symptomatic hypoglycemia in the newborn // Indian Pediatr. 1971. Vol. 8. P. 762–769.
129. Levitsky L. L., Fisher D. E., Paton J. B. Fasting plasma levels of glucose, acetoacetate, D-hydroxybutyrate, glycerol and lactate in the baboon infant: correlation with cerebral uptake of substrates and oxygen // Pediatric research. 1977. Vol. 11. P. 298–302.
130. Lilien L. D., Pildes R. S., Srinivasan G., Voora S., Yeh T. F. Treatment of neonatal hypoglycemia with minibolus and intraveous glucose infusion // J. Pediatr. 1980. Vol. 97. P. 295–298.
131. Lilien L. D., Rosenfield R. L., Baccaro М. М., Pildes R. S. Hyperglycemia in stressed small premature neonates // J Pediatr. 1979. Vol. 94. P. 454–459.
132. Limesand S. W., Jensen J., Hutton J. C., Hay W. W. Jr. Diminished (3-Cell Replication Contributes to Reduced (3-Cell Mass in Fetal Sheep with Intrauterine Growth Restriction // Am. J. Physiol. Reg. Integr. Comp. Physiol. 2005. Vol. 288. P. 1297–1305.
133. Limesand S. W., Rozance P. J., Zerbe G. O., Hutton J. C., Hay W. W. Jr. Attenuated Insulin Release and Storage in Fetal Sheep Pancreatic Islets with Intrauterine Growth Restriction // Endocrinology. 2006. Vol. 147. P. 1488–1497.
134. Louik C., Mitchell A. A., Epstein M. F., Shapiro S. Risk factors for neonatal hyperglycemia associated with 10 % dextrose infusion//Am. J. Dis. Child., 1985. Vol. 193. P. 783–786.
135. LteifA. N., Schwenk W. F. Hypoglycemia in infants and children // Endocrinol. Metab. Clin. North. Am. 1999. Vol. 28. P. 619–646.
136. Lubchenco L. O., Bard H. Incidence of hypoglycemia in newborn infants classified by birth weight and gestational age // Pediatrics. 1971. Vol. 47. P. 831–838.
137. Lucas A., Boyes S., Bloom S. R., Aynsley-Green A. Metabolic and endocrine responses to a milk feed in six-day-old term infants: differences between breast and cow’s milk formula feeding //Acta paediatrica Scandinavica. 1981. Vol. 70. P. 195–200.
138. Lucas A., Morley R., Cole T. J. Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia // British medical journal (BMJ). 1988. Vol. 297. P. 1304–1308.
139. van der Lugt N. М., Smits-Wintjens V. E., van Zwieten P. H., Walther F. J. Short and long term outcome of neonatal hyperglycemia in very preterm infants: a retrospective follow-up study // BMC Pediatr. 2010. Vol. 10. P. 52–56.
140. MacMullen C., Fang J., Hsu B. Y., Kelly A., de Lonlay-Debeney P., Saudubray J. М., Ganguly A., Smith T. J., Stanley C. A. Hyperinsulinism/hyperammonemia syndrome in children with regulatory mutations in the inhibitory guanosine triphosphate-bind-ing domain of glutamate dehydrogenase // J. Clin. Endocrinol. Metab. 2001. Vol. 86. P. 1782–1787.
141. Marquis E., Robert J. J., Bouvattier C., Bellanne-Chantelot C., Junien C., Diatloff-Zito C. Major difference in aetiology and phenotypic abnormalities between transient and permanent neonatal diabetes // J. Med. Genet. 2002. Vol. 39, N 5. P. 370–374.
142. McCowen К. C., Malhotra A., Bistrian B. R. Stress-induced hyperglycemia // Crit. Care Clin. 2001. Vol. 17, N 1. P. 107–124.
143. McGowan J. E., Price-Douglas W., Hay W. W. Jr. Glucose homeostasis // Handbook of Neonatal Intensive Care. 6 / Merenstein G., Gardner S., editors. St. Louis: Mosby-Elsevier; 2006. P. 368–390.
Читать дальше
Конец ознакомительного отрывка
Купить книгу